View Document Preview and Link Document Date: 2009-03-31 15:19:36 Open Document File Size: 420,65 KB Share Result on Facebook
Currency pence / / Event Product Issues / / IndustryTerm resuscitative equipment / opioid combination products / chemical name / few system applications / healthcare professional / / MedicalCondition clinically significant hypoventilation / pulmonary condition / hypoventilation / postural syncope / severe chronic pain / fainting / severe bronchial asthma DURAGESIC / alcohol abuse / nausea / fatal respiratory depression / paralytic ileus / orthostatic hypotension / vomiting / pain / drowsiness / mental illness / bradycardia / significant respiratory depression / hypersensitivity / respiratory depression / cough / depression / / MedicalTreatment day surgeries / pain management / / Organization World Health Organization / DOSAGE AND ADMINISTRATION / Federation of State Medical Boards Model Policy / American Pain Society / WARNINGS / PRECAUTIONS / Agency for Health Research and Quality / / Product Naloxone / acetaminophen / itraconazole / Duragesic / ketoconazole / fentanyl / clarithromycin / Patients / gradually following initial DURAGESIC / / Technology Pharmacokinetics / drug delivery / PHARMACODYNAMICS / / SocialTag 
Duragesic Label Page 1 Full Prescribing Information FOR USE IN OPIOID-TOLERANT PATIENTS ONLY DURAGESIC® contains a high concentration of a potent Schedule II opioid agonist,